The Klinique Medical Clinic Public Company Limited

SET:KLINIQ Stock Report

Market Cap: ฿6.8b

Klinique Medical Clinic Valuation

Is KLINIQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KLINIQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KLINIQ (THB30.75) is trading above our estimate of fair value (THB27.51)

Significantly Below Fair Value: KLINIQ is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KLINIQ?

Key metric: As KLINIQ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KLINIQ. This is calculated by dividing KLINIQ's market cap by their current earnings.
What is KLINIQ's PE Ratio?
PE Ratio22.4x
Earnings฿301.38m
Market Cap฿6.77b

Price to Earnings Ratio vs Peers

How does KLINIQ's PE Ratio compare to its peers?

The above table shows the PE ratio for KLINIQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.5x
MEDEZE Medeze Group
28.9x24.4%฿8.5b
SAFE Safe Fertility Group
18.6x11.8%฿3.6b
GFC Genesis Fertility Center
17.8x10.9%฿1.5b
D Dental Corporation
20.6xn/a฿1.1b
KLINIQ Klinique Medical Clinic
22.4x17.8%฿6.8b

Price-To-Earnings vs Peers: KLINIQ is expensive based on its Price-To-Earnings Ratio (22.4x) compared to the peer average (21.5x).

Price to Earnings Ratio vs Industry

How does KLINIQ's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
KLINIQ 22.4xIndustry Avg. 22.0xNo. of Companies7PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KLINIQ is expensive based on its Price-To-Earnings Ratio (22.4x) compared to the TH Healthcare industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is KLINIQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KLINIQ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.4x
Fair PE Ratio24.8x

Price-To-Earnings vs Fair Ratio: KLINIQ is good value based on its Price-To-Earnings Ratio (22.4x) compared to the estimated Fair Price-To-Earnings Ratio (24.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KLINIQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current฿30.75
฿43.12
+40.2%
15.4%฿52.00฿36.00n/a3
Nov ’25฿32.00
฿47.83
+49.5%
6.3%฿52.00฿45.00n/a3
Oct ’25฿36.50
฿47.83
+31.1%
6.3%฿52.00฿45.00n/a3
Sep ’25฿36.00
฿47.83
+32.9%
6.3%฿52.00฿45.00n/a3
Aug ’25฿36.75
฿51.17
+39.2%
9.7%฿58.00฿46.50n/a3
Jul ’25฿42.50
฿54.83
+29.0%
10.8%฿60.00฿46.50n/a3

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Master Style

฿12.7b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿42.25

7D

-8.2%

1Y

-7.1%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.28

7D

3.7%

1Y

12.0%

Safe Fertility Group

฿3.6b

Provides fertility medical center services in Thailand.

SAFE

฿12.00

7D

-0.8%

1Y

-33.0%